Primecap Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-542,100
| Closed | -$40.8M | – | 342 |
|
|
2022
Q2 | $40.8M | Buy |
542,100
+590
| +0.1% | +$44.4K | 0.04% | 184 |
|
|
2022
Q1 | $14.5M | Sell |
541,510
-2,500
| -0.5% | -$67.1K | 0.01% | 245 |
|
|
2021
Q4 | $25.9M | Buy |
544,010
+24,380
| +5% | +$1.16M | 0.02% | 229 |
|
|
2021
Q3 | $34.5M | Sell |
519,630
-1,930
| -0.4% | -$128K | 0.02% | 211 |
|
|
2021
Q2 | $40.7M | Buy |
521,560
+55,320
| +12% | +$4.32M | 0.03% | 205 |
|
|
2021
Q1 | $44.1M | Buy |
466,240
+14,900
| +3% | +$1.41M | 0.03% | 200 |
|
|
2020
Q4 | $55M | Buy |
451,340
+9,740
| +2% | +$1.19M | 0.04% | 182 |
|
|
2020
Q3 | $38.6M | Sell |
441,600
-13,400
| -3% | -$1.17M | 0.03% | 184 |
|
|
2020
Q2 | $29.4M | Buy |
+455,000
| New | +$29.4M | 0.03% | 188 |
|